New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2013
07:16 EDTECYT, SGENEndocyte added to Top Picks list; Seattle Genetics removed at Credit Suisse
Credit Suisse added Endocyte to the Top Picks list based on vintafolide regulatory and clinical events over the next 12 months, a strong cash position, and asset ownership, among other reasons.
News For ECYT;SGEN From The Last 14 Days
Check below for free stories on ECYT;SGEN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 12, 2014
09:01 EDTSGENSeattle Genetics initiates Phase 1 trial of SGN-CD70A
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use